🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2a, randomized, double blind, parallel group, multicenter s...
Status
Completed
Location
University of Alabama at Birmingham, Dermatology at the Whitaker Clinic
Start Date
2016-12-15
Trial ID
NCT02974868
Treatments Being Tested
PF-06700841 is a dual Tyrosine kinase 2 (TYK2) Janus kinase 1 (JAK1) inhibi...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2019-01-07
Trial ID
NCT03765554
Treatments Being Tested
This is a study with 3 kinase inhibitors (PF 06650833, PF 06700841 and PF 0...
Status
Completed
Location
The University Of Alabama At Birmingham
Start Date
2019-12-02
Trial ID
NCT04092452
Treatments Being Tested
Alopecia could be subdivided into two main groups of diseases: non-scarring...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2021-05-19
Trial ID
NCT05076006
Treatments Being Tested
This is a Phase 2b, randomized, double blind, parallel group, multicenter s...
Status
Completed
Location
Marvel Research, LLC
Start Date
2018-11-26
Trial ID
NCT03715829
The objectives of this study are to evaluate the efficacy, safety, tolerabi...
Status
Completed
Location
Dothan Surgery Center
Start Date
2018-02-02
Trial ID
NCT03395184
Treatments Being Tested
The purpose of this study is to characterize the effect of kidney impairmen...
Status
Completed
Location
Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy
Start Date
2020-07-03
Trial ID
NCT04260464
Treatments Being Tested
An open-label, fixed sequence, 2-period including a single oral dose 60 mg ...
Status
Completed
Location
PRA Health Sciences
Start Date
2018-12-10
Trial ID
NCT03770039
This is a Phase 1, single center, randomized, vehicle and white petrolatum ...
Status
Completed
Location
Medical Corporation Heishinkai OPHAC Hospital
Start Date
2019-03-23
Trial ID
NCT03916250
Treatments Being Tested
A phase 1, 6-sequence, 3-period, subject- and investigator blinded and spon...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2018-09-05
Trial ID
NCT03656952
Treatments Being Tested